Mirae Asset Global Investments’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,718
Closed -$439K 1555
2024
Q1
$439K Sell
31,718
-11,347
-26% -$96.4K ﹤0.01% 1956
2023
Q4
$314K Buy
43,065
+10,162
+31% +$80.1K ﹤0.01% 2178
2023
Q3
$299K Buy
32,903
+1,185
+4% +$14.2K ﹤0.01% 2129
2023
Q2
$386K Hold
31,718
﹤0.01% 2066
2023
Q1
$394K Buy
31,718
+1,087
+4% +$20K ﹤0.01% 2039
2022
Q4
$589K Hold
30,631
﹤0.01% 1797
2022
Q3
$575K Buy
30,631
+9,180
+43% +$189K ﹤0.01% 1791
2022
Q2
$387K Buy
+21,451
New +$348K ﹤0.01% 1868

Other funds holding AHCO

Mirae Asset Global Investments's AHCO Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 31,718 shares — an estimated $439K sold.

Mirae Asset Global Investments first reported a position in AHCO in Q2 2022 and held it in 8 quarters. The position peaked at $589K in Q4 2022. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 31,718 AdaptHealth shares in Q2 2024, an estimated $439K.
  • Mirae Asset Global Investments first reported a position in AdaptHealth in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's AdaptHealth position peaked at $589K in Q4 2022.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.